These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8216563)

  • 41. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ; Falsey AR; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2015 Feb; 33(9):1151-9. PubMed ID: 25613721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
    Gambel JM; DeFraites R; Hoke C; Brown A; Sanchez J; Karabatsos N; Tsai T; Meschievitz C
    J Infect Dis; 1995 Apr; 171(4):1074. PubMed ID: 7706798
    [No Abstract]   [Full Text] [Related]  

  • 43. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study of the reactogenicity and immunogenicity of new Soviet and commercial vaccines for preventing Japanese encephalitis].
    Sumarovkov AA; Grachev VP; Kharazian EG; Shkol'nik RIa; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):74-9. PubMed ID: 6314716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of pregnancy on protection of mice immunized by Japanese encephalitis virus & its experimental inactivated vaccine.
    Soni GR
    Indian J Med Res; 1994 Aug; 100():57-8. PubMed ID: 7927555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Determination of the optimal dose of a cultured inactivated vaccine for preventing Japanese encephalitis].
    Grachev VP; Sumarokov AA; Kharazian EG; Shkol'nik RIa; Karinskaia GA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):98-103. PubMed ID: 6322486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety & efficacy of Japanese encephalitis vaccine produced in India.
    Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I
    Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169
    [No Abstract]   [Full Text] [Related]  

  • 48. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.
    Tafuku S; Miyata T; Tadano M; Mitsumata R; Kawakami H; Harakuni T; Sewaki T; Arakawa T
    Microbes Infect; 2012 Feb; 14(2):169-76. PubMed ID: 22001496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)].
    Van der Vliet D; Simons de Fanti A; Murri S; Lapidus N; Goujon C; Zeller H; Consigny PH
    Med Trop (Mars); 2010 Apr; 70(2):155-7. PubMed ID: 20486351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an effective Japanese encephalitis virus-specific DNA vaccine.
    Wu CJ; Li TL; Huang HW; Tao MH; Chan YL
    Microbes Infect; 2006 Sep; 8(11):2578-86. PubMed ID: 16949850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
    Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
    Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Levels of HI antibody against Japanese encephalitis virus and the effect of vaccination in inpatients of a tuberculosis sanatorium in Fukuoka City].
    Kusaba T; Ichiki T; Nagai K; Tachibana N; Matsumoto I
    Kansenshogaku Zasshi; 1972 Jul; 46(7):240-5. PubMed ID: 4347344
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative safety and efficacy of subcutaneous and intradermal administration of inactivated Japanese encephalitis vaccine during predeployment preparations in the Australian Defence Force.
    Kitchener S; Nasveld P; Brennan L; Ward D
    Mil Med; 2006 Dec; 171(12):1190-5. PubMed ID: 17256680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.